Acetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Significant Improvements in MRI-PDFF in a Phase 2, Randomized, Placebo-Controlled Trial of Patients with NASH

Press/Media: Press / Media

PeriodOct 27 2017

Media coverage

1

Media coverage

  • TitleAcetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Significant Improvements in MRI-PDFF in a Phase 2, Randomized, Placebo-Controlled Trial of Patients with NASH
    Media name/outletNational AIDS Treatment Advocacy Project
    CountryUnited States
    Date10/27/17
    PersonsEric J Lawitz